How to evaluate and predict the epidemiologic impact of antibiotic use in humans: The pharmacoepidemiologic approach

Clinical Microbiology and Infection

Volumn 7, Issue SUPPL. 5, 2001, Pages 19-23

  Guillemot, D ^a,b  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; FORECASTING; GENETICS; HUMAN; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PROPORTIONAL HAZARDS MODEL; REVIEW; STANDARD; THEORETICAL MODEL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FORECASTING; GUIDELINES; HUMANS; MODELS, THEORETICAL; PHARMACOEPIDEMIOLOGY; PROPORTIONAL HAZARDS MODELS;

EID: 18844482562     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2001.00069.x     Document Type: Article

References (42)

1. Strom B. Pharmacoepidemiology, 2nd edn. Chichester: John Wiley & Son Ltd, 1994.
2. Flament-Saillour M, Robert J, Jarlier V, Grosset J. Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. Am J Respir Crit Care Med 1999; 160: 587-93.
3. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest 1998; 114: 1244-52.
4. Harthug S, Eide GE, Langeland N. Nosocomial outbreak of ampicillin resistant Enterococcus faecium: risk factors for infection and fatal outcome. J Hosp Infect 2000; 45: 135-44.
5. Orloff SL, Busch AM, Olyaei AJ et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 1999; 177: 418-22.
6. Newell KA, Millis JM, Arnow PM et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998; 65: 439-42.
7. Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 2000; 30: 466-72.
8. Caballero-Granado FJ, Cisneros JM, Luque R et al. Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. J Clin Microbiol 1998; 36: 520-5.
9. Guillemot D, Gasquet I, Vallet O, David M, Laurent C, Mathieu D. Is bacterial resistance increasing mortality in nosocomial infection? In: 10th ECCMID. Stockholm: European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 2000; 6 (Suppl. 1): 119 [TuO18]
10. Hill A. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
11. Baquero F. Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview. Microb Drug Resist 1995; 1: 115-20.
12. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999; 341: 233-9.
13. Dowell SF, Schwartz B, Phillips WR. Appropriate use of antibiotics for URIs in children: Part I. Otitis media and acute sinusitis. The Pediatric URI Consensus Team. Am Fam Physician 1998; 58: 1113-8, 1123.
14. Dowell SF, Schwartz B, Phillips WR. Appropriate use of antibiotics for URIs in children: Part II. Cough, pharyngitis and the common cold. The Pediatric URI Consensus Team. Am Fam Physician 1998; 58: 1335-42, 1345.
15. Huovinen P, Seppala H, Kataja J, Klaukka T. The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance. Ciba Found Symp 1997; 207: 36-41.
16. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995; 21: 1378-85.
17. Miller YW, Eady EA, Lacey RW, Cove JH, Joanes DN, Cunliffe WJ. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996; 38: 829-37.
18. Eady EA. Bacterial resistance in acne. Dermatology 1998; 196: 59-66.
19. Guillemot D, Boutou O, Carbon C et al. Penicillin-resistant Streptococcus pneumoniae (PRSp) carriage is strongly related to β-lactam use. In: 38th ICAAC San Diego ASM. 1998; C24:75.
20. Baquero F. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J Chemother 1999; 11 (Suppl. 1): 35-43.
21. Guillemot D, Carbon C, Balkau B et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279: 365-70.
22. Schrag SJ, Perrot V. Reducing antibiotic resistance. Nature 1996; 381: 120-1.
23. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441-6.
24. Kristinsson KG. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb Drug Resist 1997; 3: 117-23.
25. Kristinsson KG, Hjalmarsdottir MA, Steingrimsson O. Increasing penicillin resistance in pneumococci in Iceland. Lancet 1992; 339: 1606-7.
26. Kristinsson KG. Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist 1995; 1: 121-5.
27. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96: 1152-6.
28. Kataja J, Huovinen P, Muotiala A et al. Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis 1998; 177: 786-9.
29. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J Infect Dis 1993; 168: 158-63.
30. Schwartz B. Preventing the spread of antimicrobial resistance among bacterial respiratory pathogens in industrialized countries: the case for judicious antimicrobial use. Clin Infect Dis 1999; 28: 211-3.
31. Guillemot D, Carbon C. Antibiotic use and pneumococcal resistance to penicillin - 'The French experience'. CMI 1999; 5: 38-42.
32. Guillemot D, Carbon C, Thibult N, Lecoeur H, Weber P, Eschwege E. Macrolide use is associated with macrolide resistant (MRSp) and penicillin resistant (PRSp) Streptococcus pneumoniae. In: 40th ICAAC. Toronto: ASM, 2000; 1863:1.
33. Lipsitch M, Levin BR. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int J Tuberc Lung Dis 1998; 2: 187-99.
34. Bonhoeffer S, Lipsitch M, Levin BR. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 1997; 94: 12106-11.
35. Lipsitch M, Levin BR. The population dynamics of antimicrobial chemotherapy. Antimicrob Agents Chemother 1997; 41: 363-73.
36. Lipsitch M, Levin BR. The within-host population dynamics of antibacterial chemotherapy: conditions for the evolution of resistance. Ciba Found Symp 1997; 207: 112-27.
37. Austin DJ, Kakehashi M, Anderson RM. The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc R Soc Lond B Biol Sci 1997; 264: 1629-38.
38. Lipsitch M, Bergstrom CT, Levin BR. From the cover, the epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci USA 2000; 97: 1938-43.
39. Sebille V, Valleron AJ. A computer simulation model for the spread of nosocomial infections caused by multidrug-resistant pathogens. Comput Biomed Res 1997; 30: 307-22.
40. Witte W. Medical consequences of antibiotic use in agriculture. Science 1998; 279: 996-7.
41. Levin BR, Antia R, Berliner E et al. Resistance to antimicrobial chemotherapy: a prescription for research and action. Am J Med Sci 1998; 315: 87-94.
42. Bax RP, Anderson R, Crew J et al. Antibiotic resistance - what can we do? Nat Med 1998; 4: 545-6.